Wird geladen...
IT-06 PERSONALIZED IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA
BACKGROUND: Immunotherapy harnesses the immune system to specifically attack malignant cells thereby offering a targeted treatment option without systemic toxicity for patients with GBM. However, immunotherapy remains limited by the relative dearth of antigen specific tumor targets. Since GBMs have...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218256/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|